This imaging can visualize and quantify renal SGLT2 activity, potentially allowing for precise monitoring of SGLT2 inhibitor efficacy in reducing glomerular hyperfiltration and protecting against CKD progression 51. Here, SLC5A2 is linked to chronic kidney disease.